Measurable Residual Disease in ALL: Proof of the Principle Transforming Care for Patients With Hematologic Malignancies

Take advantage of these resources for using MRD as a tool during management of patients with ALL. Watch an expert panel discussion or one of several patient-focused short videos read concise expert commentaries and download the slideset and clinical resource PDF.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Activities

MRD in ALL: Resource Guide
At a Glance: Assessing Measurable Residual Disease in Acute Lymphoblastic Leukemia
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: December 20, 2018

Expires: December 19, 2019

Faculty

cover img faculity

Elias Jabbour, MD

Assistant Professor
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Houston, Texas

cover img faculity

Joseph D. Khoury, MD

Professor
Department of Hematology
The University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Aaron C. Logan, MD, PhD

Associate Professor
Division of Hematology and Blood and Marrow Transplantation
University of California, San Francisco
San Francisco, California

Provided by

ProCE Banner

Supporters

This activity is supported by educational grants from

Adaptive Biotechnologies

Amgen, Inc.

Partners

GRACE

ProCE Banner